LACOSAMIDE
ANTICONVULSANTS · FOCAL EPILEPSY ·+2
CHARTWELL GOVER
Drug class
Anticonvulsant - Functionalized Amino Acid
The drug class descriptor "Anticonvulsant - Functionalized Amino Acid" designates a chemical and therapeutic subclass of antiepileptic agents structurally derived from D-serine, prototyped by lacosamide. Read more about Anticonvulsant - Functionalized Amino Acid
49 drugs in this class 46 manufacturers
Drugs in Anticonvulsant - Functionalized Amino Acid
LACOSAMIDE
ANTICONVULSANTS · FOCAL EPILEPSY ·+2
AVKARE
LACOSAMIDE
ANTICONVULSANTS · FOCAL EPILEPSY ·+2
AVPAK
LACOSAMIDE
ANTICONVULSANTS · FOCAL EPILEPSY ·+2
KANCHAN HEALTHC
Filter & compare in the drug finder →
Opens the drug finder with Anticonvulsant - Functionalized Amino Acid preselected. Add indication or manufacturer filters there.
The drug class descriptor "Anticonvulsant - Functionalized Amino Acid" designates a chemical and therapeutic subclass of antiepileptic agents structurally derived from D-serine, prototyped by lacosamide.
Agents in this class exert their primary therapeutic effect by selectively enhancing the slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes and curbing repetitive, high-frequency neuronal firing without disrupting physiological fast inactivation.
Clinically, these agents are indicated for the management of epilepsy, specifically as monotherapy or adjunctive therapy for partial-onset seizures and primary generalized tonic-clonic seizures.
-
fda.gov
The drug class descriptor "Anticonvulsant - Functionalized Amino Acid" designates a chemical and therapeutic subclass of antiepileptic agents structurally derived from D-serine, prototyped by lacosamide
-
nih.gov
The drug class descriptor "Anticonvulsant - Functionalized Amino Acid" designates a chemical and therapeutic subclass of antiepileptic agents structurally derived from D-serine, prototyped by lacosamide Agents in this class exert their primary therapeutic effect by selectively enhancing the slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes and curbing repetitive, high-frequency neuronal firing without disrupting physiological fast inactivat...
-
nih.gov
Agents in this class exert their primary therapeutic effect by selectively enhancing the slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes and curbing repetitive, high-frequency neuronal firing without disrupting physiological fast inactivation
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.